Search Results
Oct 27, 2025, 08:00 ET New Oshi Health Research at ACG 2025 Demonstrates Improved Outcomes and Cost Savings At Scale Through Virtual, Multidisciplinary GI Care
better symptom control and quality of life, while lowering the likelihood of costly urgent care escalations and avoidable care," said Sameer Berry, MD, MBA, Co-founder and Chief Medical Officer at Oshi Health. "Because of our patient volume, excellence in managing complex cases, and clinicians practicing
More news about: Oshi Health
Oct 27, 2025, 07:47 ET Parkland Reports 2025 Third Quarter Results and Provides Update on the Sunoco Transaction
MD&A and Annual Consolidated Financial Statements The Management's Discussion and Analysis for the three and nine months ended September 30, 2025 (the "Q3 2025 MD&A") and Interim Condensed Consolidated Financial
More news about: Parkland Corporation
Oct 27, 2025, 07:45 ET New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis
Alzheimer's disease pathology, supporting diagnosis and advancing patient care for Alzheimer's disease in the intended use patients," said Michael Racke, MD, a board-certified neurologist and Senior Medical Director of Neurology, Quest Diagnostics. "Our analysis also suggests that blood-based testing can achieve
More news about: Quest Diagnostics
Oct 27, 2025, 07:30 ET TREMFYA® (guselkumab), the first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn's disease at two years
TREMFYA®. "Crohn's disease is a chronic condition that can greatly impact a patient's quality of life," said David Rubin, MD, Director of the Inflammatory Bowel Disease Center at the University of Chicago.e "These results show that guselkumab can provide endoscopic
More news about: Johnson & Johnson
Oct 27, 2025, 07:29 ET Alphyn Expands Patent Estate with New U.S. Patent for Atopic Dermatitis Therapeutic
pharmaceutical ingredient with protection until 2041 ANNAPOLIS, Md., Oct. 27, 2025 /PRNewswire/ --
More news about: Alphyn Biologics, Inc.
Oct 27, 2025, 07:14 ET Xcellerant Ventures and Jetstream Founder John Shufeldt Establish the John Shufeldt School of Medicine and Medical Engineering at Arizona State University
establishes a groundbreaking medical school that unites medicine, engineering, and entrepreneurship. The school will prepare students to earn both an MD and a Master of Science in Medical Engineering, training the next generation of clinician-innovators equipped to transform patient care through technology,
More news about: Xcellerant Ventures
Oct 27, 2025, 07:00 ET China's NMPA Grants Breakthrough Therapy Designation for Anti-CTLA-4 Antibody Candidate Gotistobart (BNT316/ONC-392)
in squamous non-small cell lung cancer Is Ongoing ROCKVILLE, Md., Oct. 27, 2025 /PRNewswire/ -- OncoC4 announced today that China's National Medical Product Administration (NMPA)
More news about: OncoC4
Oct 27, 2025, 07:00 ET VERSABANK UNVEILS BRANDING FOR PROPREITARY DIGITAL DEPOSIT RECEIPTS: VERSABANK REAL BANK DEPOSIT TOKENS™ REFLECTS CRITICAL ADVANTAGE OF ISSUANCE BY A FEDERALLY LICENSED BANK
the risks implicated by the foregoing. For a detailed discussion of certain key factors that may affect our future results, please see our annual MD&A for the year ended October 31, 2024. The foregoing list of important factors is not exhaustive. When relying on forward-looking
More news about: VersaBank
Oct 27, 2025, 06:51 ET "Trick or Treat": Helping Children Who Have Speech or Language Disorders Enjoy a Halloween Tradition
Parents and Caregivers ROCKVILLE, Md., Oct. 27, 2025 /PRNewswire/ -- Trick-or-treating is a favorite Halloween ritual, but for children who have speech
More news about: American Speech-Language-Hearing Association (ASHA)
Oct 27, 2025, 06:00 ET Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
financing validate our approach and enable us to continue building what we believe will become the ultimate clotting company," said Benny Sorensen, MD, PhD, CEOof Hemab. "We carefully listen to people living with clotting diseases and collaborate closely with patients and families affected
More news about: Hemab Therapeutics
Oct 27, 2025, 02:12 ET World-Renowned Surgeon and Entrepreneur Dr. Mandeep S. Dhalla Invests in DentScribe.ai and Joins as Strategic Advisor
platform that transforms dental SOAP notes into real-time clinical checklists and practice growth signals, today announced that Dr. Mandeep S. Dhalla, MD, has invested in the company and joined as a Strategic Advisor.
More news about: DentScribe
Oct 26, 2025, 21:14 ET NetDragon and Open University Malaysia Sign Strategic MOU to Jointly Explore New Models of AI-Powered Open Education
(Learner Experience and Technology) of OUM. The MOU was signed by Mr. Chen Hong, Senior Vice President of NetDragon, and Prof. Datuk Dr. Mohd Tajudin Md Ninggal, Vice President/Deputy Vice-Chancellor (Academic and Research) of OUM. Under the MOU, both parties will adhere to the
More news about: NetDragon Websoft Holdings Limited
Oct 26, 2025, 20:00 ET Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3
molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Roche, Takeda,Sanofi, Incyte, LG Chem and MD Anderson Cancer Center. Guided by the motto, "Start with Integrity, Succeed through Action" Innovent maintains the highest standard
More news about: Innovent Biologics
Oct 26, 2025, 15:00 ET Cristcot to Present Data on Novel Ulcerative Colitis Treatment at the American College of Gastroenterology 2025 Annual Meeting
is an urgent need for a fast-acting, localized, and easy-to-administer option to manage patients with active ulcerative colitis," said Raj Devarajan, MD, Global Medical Advisor, Cristcot, and presenting author. "I'm thrilled to share the pivotal CESSA trial results as a Presidential Poster at ACG, which
More news about: Cristcot
Oct 26, 2025, 13:00 ET Real-World Data Presented at TCT 2025 Demonstrates the EggNest™ Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team
Light Lead Apron. Raviteja Guddeti, MD, Korey Haddox, DO, Stephen Rudick, MD, Jarrod Frizzell, MD, Christian W. Schmidt, MS, PhD, Sitaramesh Emani, MD, Timothy D. Henry, MD, Dean J. Kereiakes, MD, Robert Riley, MD, MS, Puvi Seshiah, MD, James Kong, MD, John D. Corl, MD, Samantha Tribble, RN, Becca Harper,
More news about: Egg Medical
Oct 26, 2025, 13:00 ET Real-World Data Presented at TCT 2025 Demonstrates the EggNest™ Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team
Light Lead Apron. Raviteja Guddeti, MD, Korey Haddox, DO, Stephen Rudick, MD, Jarrod Frizzell, MD, Christian W. Schmidt, MS, PhD, Sitaramesh Emani, MD, Timothy D. Henry, MD, Dean J. Kereiakes, MD, Robert Riley, MD, MS, Puvi Seshiah, MD, James Kong, MD, John D. Corl, MD, Samantha Tribble, RN, Becca Harper,
More news about: Egg Medical
Oct 24, 2025, 15:29 ET The Inner Circle acknowledges, LaToya C. James, VP as an Inner Circle Lifetime Member
BURTONSVILLE, Md., Oct. 24, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle, LaToya C. James, VP is recognized as an Inner Circle Lifetime Member for her contributions to Driving
More news about: The Inner Circle
Oct 24, 2025, 14:39 ET Laplace Interventional completes Trans-Jugular US Early Feasibility Study and adds Trans-Femoral approach
were successfully treated using the TF approach by Irakli Gogorishvili, MD, and Gvantsa Dughashvili, MD at Healthycore in Tbilisi, Republic of Georgia, with support from structural heart experts from the United States, Kashish Goel, MD and Lucy Safi, DO. Laplace Interventional's device
More news about: Laplace Interventional, Inc.
Oct 24, 2025, 14:23 ET VISION26 Brings AI Insights & CME Opportunity to Washington, DC
GREENBELT, Md., Oct. 24, 2025 /PRNewswire/ -- Center for Vein Restoration (CVR), the nation's largest physician-led vein center, announced VISION26, its annual conference advancing venous
More news about: Center for Vein Restoration
Oct 24, 2025, 14:15 ET InventHelp Inventor Develops New Tire Disable Product for Police (RKH-855)
/PRNewswire/ -- "I wanted to create a way for police to stop a dangerous suspect from fleeing in their vehicle," said an inventor, from Coltons Point, Md., "so I invented the LAW ENFORCEMENT LASER TIRE DISABLE. My design would serve as an improved alternative to throwing spike strips out across the road
More news about: InventHelp
Oct 24, 2025, 13:25 ET Opportunity Finance Network Honors Congressional Leaders for Bipartisan Support of CDFIs
Sens. Mike Rounds (R-SD) and Chris Van Hollen (D-MD) and Reps. Steve Womack (R-AR-3) and Nydia Velázquez (D-NY-7) named 2025 CDFI Congressional Champions WASHINGTON,
More news about: Opportunity Finance Network
Oct 24, 2025, 13:15 ET TOA Waters Launches the World's First and Only Liquid Bath Bombs
Glitter Balls. Liquid Bath Bombs have arrived. FREDERICK, Md., Oct. 24, 2025 /PRNewswire/ -- TOA Waters, the bold self-care small business known for breaking gender stereotypes
More news about: TOA Waters
Oct 24, 2025, 13:02 ET Jonathan M. Magid, M.D. Offering Patients the Hybrid Choice™ Concierge Program from Concierge Choice Physicians
Physicians at (877) 888-5590. About Jonathan Magid, MD ,Dr. Magid is board certified in Internal Medicine. After graduating Magna Cum Laude from University of Texas in
More news about: CONCIERGE CHOICE PHYSICIANS
Oct 24, 2025, 12:30 ET Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
BETHESDA, Md., Oct. 24, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies
More news about: Northwest Biotherapeutics, Inc.
Oct 24, 2025, 12:30 ET Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC
"These results emphasize the translational potential of PTK7 as a broadly expressed and stable target across solid tumors," said Grace Dy, MD, Chief, Thoracic Oncology, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center. "By demonstrating consistent expression
More news about: Whitehawk Therapeutics, Inc.